GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

anrikefon   Click here for help

GtoPdb Ligand ID: 14403

Synonyms: compound 8 [US11014964] | HSK-21542 | HSK21542 | Si Shu Jing® (China)
Approved drug
anrikefon is an approved drug
Compound class: Peptide
Comment: Anrikefon (HSK21542) is a novel and selective peripheral kappa opioid receptor (KOR) agonist [3]. It has actions as an analgesic and anti-itch (anti-pruritic) agent.
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)C[C@H](C(=O)N[C@H](CCCCN)C(=O)N1CCC2(CC1)CN(C2)C(=O)C)NC(=O)[C@@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CC=CC=C4)N
Isomeric SMILES CC(C)C[C@H](C(=O)N[C@H](CCCCN)C(=O)N1CCC2(CC1)CN(C2)C(=O)C)NC(=O)[C@@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CC=CC=C4)N
InChI InChI=1S/C39H57N7O5/c1-27(2)22-33(36(49)42-32(16-10-11-19-40)38(51)45-20-17-39(18-21-45)25-46(26-39)28(3)47)44-37(50)34(24-30-14-8-5-9-15-30)43-35(48)31(41)23-29-12-6-4-7-13-29/h4-9,12-15,27,31-34H,10-11,16-26,40-41H2,1-3H3,(H,42,49)(H,43,48)(H,44,50)/t31-,32-,33-,34-/m1/s1
InChI Key VWXDZAZSCZVCPV-YFRBGRBWSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Jing R, Zhi X, Shao L. (2026)
Approvals by the China NMPA in 2025.
Nat Rev Drug Discov, [Epub ahead of print]. [PMID:41688808]
2. Liu BC, Li ZL, Zhang P, Zhong AM, Bai YL, Xu Y, Gao BH, Li YL, Wang Y, Zhou LH et al.. (2025)
Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial.
BMJ, 390: e085208. [PMID:40829896]
3. Zhang C, Huang A, Ye F, Huang L, Huang Z, Wang J, Wei Y, Yan P, Zheng W. (2021)
Peptide amide compound and preparation method and medical use thereof.
Patent number: US11014964B2. Assignee: Tibet Haisco Pharmaceutical Co Ltd. Priority date: 19/07/2018. Publication date: 25/05/2021.